MedTrace Logo

Autologous Serum Obtained by a Closed-Circuit Collection Device

NCT07014059 · Status: NOT_YET_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2025-06-10

No results posted yet for this study

Summary

Autologous serum eye drops (ASED) are an established therapy for ocular surface diseases; however, their preparation can be costly and may not be available due to the need for germ-free conditions. This pilot trial assesses the feasibility of collecting ASED in a closed-circuit system for patients with chronic ocular surface diseases.

Conditions

  • GVHD
  • Meibomian Gland Dysfunction (Disorder)
  • Stevens-Johnson Syndrome
  • Limbal Keratoconjunctivitis
  • Recurrent Erosions of Persistent Epithelial Defects
  • Neurotrophic Ulcer
  • Sjogren Syndrome With Keratoconjunctivitis

Interventions

DRUG

Autologous Serum 20%

The collection of autologous serum in a closed blood processing system for ocular use

Sponsors & Collaborators

  • JP Farma

    collaborator UNKNOWN

  • GIANCARLO FATOBENE

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-20
Primary Completion
2026-06-20
Completion
2027-06-20

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07014059 on ClinicalTrials.gov